We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
51
Adobe
ADBE
$89.5B
$29.9M 0.4%
110,682
+3,002
+3% +$774K
TSRO
52
DELISTED
TESARO, Inc.
TSRO
$29.8M 0.4%
763,500
+382,000
+100% +$13.5M
PYPL icon
53
PayPal
PYPL
$49.5B
$29.5M 0.39%
336,227
-29,122
-8% -$2.56M
MKC icon
54
McCormick & Company Non-Voting
MKC
$13.4B
$28.8M 0.38%
437,128
+17,118
+4% +$1.06M
AVGO icon
55
Broadcom
AVGO
$1.82T
$27M 0.36%
1,094,240
-438,210
-29% -$9.83M
ALL icon
56
Allstate
ALL
$66.9B
$27M 0.36%
273,078
-11,938
-4% -$1.16M
NKTR icon
57
Nektar Therapeutics
NKTR
$2.39B
$26.7M 0.36%
29,247
+20,128
+221% +$17.2M
SHW icon
58
Sherwin-Williams
SHW
$78.3B
$26.4M 0.35%
173,739
+41,574
+31% +$6.15M
PEP icon
59
PepsiCo
PEP
$186B
$26.3M 0.35%
235,323
+83,190
+55% +$9.42M
EMR icon
60
Emerson Electric
EMR
$82.9B
$26.1M 0.35%
341,457
-114,443
-25% -$8.44M
WFC icon
61
Wells Fargo
WFC
$261B
$25.2M 0.34%
480,011
-9,689
-2% -$553K
KYNB
62
Kyntra Bio
KYNB
$28.5M
$25M 0.33%
16,436
+8,912
+118% +$13.7M
ANET icon
63
Arista Networks
ANET
$219B
$24.7M 0.33%
1,488,736
+93,920
+7% +$1.6M
GE icon
64
GE Aerospace
GE
$367B
$24.2M 0.32%
447,732
+256,143
+134% +$15.8M
UNP icon
65
Union Pacific
UNP
$183B
$24.2M 0.32%
148,374
+24,564
+20% +$3.7M
PRU icon
66
Prudential Financial
PRU
$41.7B
$24M 0.32%
237,185
+10,918
+5% +$1.08M
PFE icon
67
Pfizer
PFE
$140B
$23.8M 0.32%
568,051
-47,403
-8% -$1.82M
LOXO
68
DELISTED
Loxo Oncology, Inc
LOXO
$23.5M 0.31%
137,542
+63,300
+85% +$10.6M
BIDU icon
69
Baidu
BIDU
$35.8B
$22.9M 0.3%
100,118
+15,980
+19% +$3.75M
BAP icon
70
Credicorp
BAP
$30.9B
$22.7M 0.3%
101,800
+600
+0.6% +$134K
CTXS
71
DELISTED
Citrix Systems Inc
CTXS
$22.5M 0.3%
202,410
+112,649
+125% +$12.5M
FFIV icon
72
F5
FFIV
$22.1B
$22.3M 0.3%
111,953
-24,166
-18% -$4.42M
INTC icon
73
Intel
INTC
$466B
$22.3M 0.3%
471,140
+29,029
+7% +$1.41M
CMI icon
74
Cummins
CMI
$91.7B
$22.2M 0.3%
152,026
+47,075
+45% +$6.63M
SLB icon
75
SLB Ltd
SLB
$77.8B
$21.8M 0.29%
358,200
+140,695
+65% +$9.06M

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.